Inspire Investing
WST icon

Inspire Investing’s West Pharmaceutical WST Stock Holding History

Inspire Investing’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$4.77M Sell
12,855
-265
-2% -$93.6K 0.2% 99
2026
Q2 		$4.71M Buy
13,120
+634
+5% +$194K 0.19% 104
2026
Q1 		$3.13M Buy
12,486
+3,736
+43% +$930K 0.18% 119
2025
Q4 		$2.41M Buy
8,750
+248
+3% +$67.8K 0.22% 118
2025
Q3 		$2.23M Sell
8,502
-603
-7% -$147K 0.22% 120
2025
Q2 		$1.99M Buy
9,105
+502
+6% +$107K 0.22% 115
2025
Q1 		$1.93M Sell
8,603
-2,240
-21% -$617K 0.23% 121
2024
Q4 		$3.55M Buy
10,843
+91
+0.8% +$28.6K 0.4% 50
2024
Q3 		$3.23M Buy
10,752
+535
+5% +$164K 0.33% 57
2024
Q2 		$3.37M Sell
10,217
-1,761
-15% -$622K 0.39% 49
2024
Q1 		$4.74M Sell
11,978
-1,305
-10% -$483K 0.48% 44
2023
Q4 		$4.68M Buy
13,283
+1,817
+16% +$643K 0.51% 34
2023
Q3 		$4.3M Sell
11,466
-340
-3% -$131K 0.55% 31
2023
Q2 		$4.52M Buy
11,806
+1,687
+17% +$603K 0.55% 31
2023
Q1 		$3.51M Buy
10,119
+425
+4% +$124K 0.45% 49
2022
Q4 		$2.28M Sell
9,694
-1,382
-12% -$327K 0.29% 73
2022
Q3 		$2.72M Buy
11,076
+2,012
+22% +$613K 0.39% 56
2022
Q2 		$2.74M Sell
9,064
-294
-3% -$95.7K 0.36% 55
2022
Q1 		$3.84M Sell
9,358
-255
-3% -$100K 0.44% 46
2021
Q4 		$4.51M Sell
9,613
-2,612
-21% -$1.12M 0.52% 46
2021
Q3 		$5.19M Buy
12,225
+9,717
+387% +$4.1M 0.66% 28
2021
Q2 		$901K Buy
2,508
+572
+30% +$189K 0.12% 197
2021
Q1 		$546K Buy
1,936
+711
+58% +$203K 0.08% 256
2020
Q4 		$347K Buy
+1,225
New +$344K 0.08% 368

Other funds holding WST

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
ProShare Advisors
ProShare Advisors Bethesda, Maryland $69.5B AUM 31.38% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
SEI Investments
SEI Investments Oaks, Pennsylvania $113B AUM 26.61% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.8B AUM 33.92% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return

Inspire Investing's WST Position: Q3 2026 in Review

Inspire Investing reduced its West Pharmaceutical (WST) stake by 2% in Q3 2026, selling an estimated $93.6K and leaving 12,855 shares worth $4.77M. The position accounts for 0.2% of the portfolio, ranked #99.

Inspire Investing first reported a position in WST in Q4 2020 and has held it in 24 quarters since. The position peaked at $5.19M in Q3 2021. 515 funds tracked by Wall St. Rank hold WST as of Q3 2026.

  • Inspire Investing held 12,855 shares of West Pharmaceutical worth $4.77M as of Q3 2026.
  • Inspire Investing sold 265 West Pharmaceutical shares in Q3 2026, an estimated $93.6K.
  • West Pharmaceutical made up 0.2% of Inspire Investing's portfolio in Q3 2026, its #99 holding.
  • Inspire Investing first reported a position in West Pharmaceutical in Q4 2020 and has held it in 24 quarters since.
  • Inspire Investing's West Pharmaceutical position peaked at $5.19M in Q3 2021.
  • 515 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2026.

Based on Inspire Investing's 13F filing for Q3 2026, filed 22 Oct 2026.